Trajectories of systemic agent use and associated depression- and anxiety-related health care costs among patients with psoriasis.

Milan, Raymond; LeLorier, Jacques; Latimer, Eric A; Brouillette, Marie-Josée; Holbrook, Anne; Litvinov, Ivan V; Rahme, Elham

Milan, Raymond; LeLorier, Jacques; Latimer, Eric A; Brouillette, Marie-Josée; Holbrook, Anne; Litvinov, Ivan V; Rahme, Elham.

Afiliação

Milan R; Division of Experimental Medicine, Department of Medicine, McGill University, Montréal, Quebec, Canada.
LeLorier J; Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montréal, Quebec, Canada.
Latimer EA; Faculté de Médecine, Université de Montréal, Montréal, Quebec, Canada.
Brouillette MJ; Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada.
Holbrook A; Department of Psychiatry, McGill University, Montréal, Quebec, Canada.
Litvinov IV; Douglas Mental Health University Institute, Montréal, Quebec, Canada.
Rahme E; Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montréal, Quebec, Canada.

JAAD Int ; 9: 11-22, 2022 Dec.

Article em En | MEDLINE | ID: mdl-35996750

Palavras-chave

AHCA, agglomerative hierarchical cluster analysis; CST, conventional systemic therapy; ED, emergency department; ICD, International Classification of Diseases; SA, sequence analysis; TNFi/UST, Tumor necrosis factor inhibitors and ustekinumab; anxiety; depression; health care costs; psoriasis; systemic agents; trajectories

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Health_economic_evaluation / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google